177 related articles for article (PubMed ID: 29879970)
1. Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder.
Hashmi AA; Hussain ZF; Irfan M; Khan EY; Faridi N; Naqvi H; Khan A; Edhi MM
BMC Urol; 2018 Jun; 18(1):59. PubMed ID: 29879970
[TBL] [Abstract][Full Text] [Related]
2. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
Cheng J; Huang H; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
Cancer Res; 2002 Jul; 62(14):4157-63. PubMed ID: 12124355
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of immunohistochemical expression profile of epidermal growth factor receptor in urothelial bladder cancer.
Arfaoui AT; Mejri S; Belhaj R; Karkni W; Chebil M; Rammeh S
J Immunoassay Immunochem; 2016; 37(4):359-67. PubMed ID: 26919632
[TBL] [Abstract][Full Text] [Related]
7. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
[TBL] [Abstract][Full Text] [Related]
8. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
[TBL] [Abstract][Full Text] [Related]
9. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.
Hashmi AA; Hussain ZF; Irfan M; Edhi MM; Kanwal S; Faridi N; Khan A
BMC Res Notes; 2018 Mar; 11(1):207. PubMed ID: 29587848
[TBL] [Abstract][Full Text] [Related]
11. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
[TBL] [Abstract][Full Text] [Related]
12. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues.
Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G
Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.
Andrew AS; Marsit CJ; Schned AR; Seigne JD; Kelsey KT; Moore JH; Perreard L; Karagas MR; Sempere LF
Int J Cancer; 2015 Sep; 137(5):1158-66. PubMed ID: 25556547
[TBL] [Abstract][Full Text] [Related]
15. Urothelial papilloma of the bladder: a review of 34 de novo cases.
Magi-Galluzzi C; Epstein JI
Am J Surg Pathol; 2004 Dec; 28(12):1615-20. PubMed ID: 15577681
[TBL] [Abstract][Full Text] [Related]
16. Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.
Mangrud OM; Gudlaugsson E; Skaland I; Tasdemir I; Dalen I; van Diermen B; Baak JP; Janssen EA
Hum Pathol; 2014 Jul; 45(7):1496-503. PubMed ID: 24796506
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification.
Santos L; Amaro T; Costa C; Pereira S; Bento MJ; Lopes P; Oliveira J; Criado B; Lopes C
Int J Cancer; 2003 Jun; 105(2):267-72. PubMed ID: 12673690
[TBL] [Abstract][Full Text] [Related]
18. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
Hu Z; Mudaliar K; Quek ML; Paner GP; Barkan GA
Ann Diagn Pathol; 2014 Apr; 18(2):49-52. PubMed ID: 24370460
[TBL] [Abstract][Full Text] [Related]
19. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
20. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]